On November 22, 2024, Rohan Palekar, the Chief Executive Officer of 89bio Inc, purchased 10,000 shares of the company (symbol: ETNB). Following this transaction, the insider now holds a total of 466,236 shares in the company. The purchase was documented in a SEC Filing. 89bio Inc is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate is designed to address significant unmet medical needs in these areas. The insider's recent acquisition is part of a broader trend observed over the past year, where the insider has purchased a total of 10,000 shares and sold 57,195 shares. In the same period, the company has seen 2 insider buys and 3 insider sells. Shares of 89bio Inc were trading at $8.35 each on the day of the insider's purchase, resulting in a market cap of $1.03 billion for the company.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
